Investigation Report on China's Piperacillin and Tazobactam Market 2021-2025

Investigation Report on China’s Piperacillin and Tazobactam Market 2021-2025

$2600 – $3900

According to CRI’s market research, the sales of Piperacillin and Tazobactam in the Chinese market increased year by year from 2016 to 2019.

SKU: 2105505 Category: Tags: , , ,

Description

Description
Piperacillin and Tazobactam is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (β-lactamase inhibitor). It is suitable for moderate and severe infections which are resistant to piperacillin, caused by beta-lactamase-producing bacteria that are sensitive to piperacillin and tazobactam. Piperacillin and Tazobactam were jointly developed by Pfizer, Wyeth, and Taisho Corporation of Japan. Piperacillin and tazobactam were approved in China in 1996 and were included in the national medical insurance in China in 2009. As of the end of 2020, there are more than 20 manufacturers in the piperacillin sodium and tazobactam sodium market in China, of which Pfizer Ltd has the largest market share.

According to CRI’s market research, the sales of Piperacillin and Tazobactam in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the new crown epidemic on the overall medical diagnosis and treatment services, the sales decreased from CNY1.681 billion in 2019 to CNY1.436 billion in 2020, with a year-on-year decrease of 14.6%. The CAGR of sales of piperacillin sodium and tazobactam sodium from 2016 to 2020 is 3.28%.

CRI predicts that the sales of Piperacillin and Tazobactam will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. In addition, Piperacillin/Tazobactam has good clinical effects and few adverse reactions. Piperacillin/Tazobactam is more effective and safer for the treatment of lower respiratory tract infections and urinary tract infections caused by beta-lactamase-producing strains compared with similar drugs. Based on these advantages, the sales of piperacillin and tazobactam will increase steadily in the future.

Topics Covered:
-The impact of COVID-19 on China’s Piperacillin and Tazobactam market
– Sales value of China’s Piperacillin and Tazobactam 2016-2020
– Competitive landscape of China’s Piperacillin and Tazobactam market
– Prices of Piperacillin and Tazobactam in China
– Prices of Piperacillin and Tazobactam in China by regions and manufacturers
– Analysis of factors affecting the development of China’s Piperacillin and Tazobactam market
– Prospect of China’s Piperacillin and Tazobactam market from 2021 to 2025

Additional information

Publisher

Geography Covered

Date Published

Pages

Charts

Format

Base Year

2016
Base Market Size

1261.75
Currency/Unit

CNY million
Forecast Year

2025
Market Size Forecast

2311.92
CAGR

6.96%

Table of Contents

Table of Contents 1 Relevant Concepts of Piperacillin and Tazobactam 1.1 Indications for Piperacillin and Tazobactam 1.2 Development of Piperacillin and Tazobactam in China 1.3 Governmental Approval of Piperacillin and Tazobactam in China 1.4 The Impact of COVID-19 on Piperacillin and Tazobactam sales in China 2 Sales of Piperacillin and Tazobactam in China, 2016-2020 2.1 Sales Value of Piperacillin and Tazobactam 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Piperacillin and Tazobactam 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Piperacillin and Tazobactam by Dosage Form in China, 2016-2020 2.3.1 Injection 2.3.2 Analysis of Other Dosage Form 3 Analysis of Major Piperacillin and Tazobactam Manufacturers in China in 2020 3.1 Analysis of Market Share of Major Piperacillin and Tazobactam Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Pfizer Ltd 3.2.1 Enterprise Profile 3.2.2 Sales of TAZOCIN (Pfizer Ltd’s Piperacillin and Tazobactam) in China 3.3 Zhuhai Lianbang Pharmaceutical Factory Co., Ltd. Zhongshan Branch 3.3.1 Enterprise Profile 3.3.2 Sales of Lianbangtazuoxian (Zhuhai Lianbang Pharmaceutical Factory Co., Ltd. Zhongshan Branch’s Piperacillin and Tazobactam) in China 3.4 Shangdong Anxin Pharmaceutical Co.,Ltd. 3.4.1 Enterprise Profile 3.4.2 Sales of Shangdong Anxin Pharmaceutical Co.,Ltd.’s Piperacillin Sodium/ Tazobactam Sodium in China 3.5 North China Pharmaceutical Company Ltd. 3.5.1 Enterprise Profile 3.5.2 Sales of Paitaqiang (North China Pharmaceutical Company Ltd.’s Piperacillin and Tazobactam) in China 3.6 Reyoung Pharmaceutical Co., Ltd. 3.6.1 Enterprise Profile 3.6.2 Sales of Beifubao (Reyoung Pharmaceutical Co., Ltd.’s Piperacillin and Tazobactam) in China 4 Prices of Piperacillin and Tazobactam for Different Manufacturers in China, 2020-2021 4.1 Pfizer Ltd (TAZOCIN) 4.2 Zhuhai Lianbang Pharmaceutical Factory Co., Ltd. Zhongshan Branch (Lianbangtazuoxian) 4.3 Shangdong Anxin Pharmaceutical Co., Ltd. 4.4North China Pharmaceutical Company Ltd. (Paitaqiang) 4.5 Reyoung Pharmaceutical Co., Ltd. (Beifubao) 5 Prospect of Chinese Piperacillin and Tazobactam Market, 2021-2025 5.1 Influential Factors of Chinese Piperacillin and Tazobactam Market Development 5.1.1 The Impact of COVID-19 on Chinese Piperacillin and Tazobactam Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Piperacillin and Tazobactam Injection Registration in China Chart Sales Value of Piperacillin and Tazobactam Injection over the World Chart Sales Value of Piperacillin and Tazobactam Injection in China, 2016-2020 Chart Sales Value of Piperacillin and Tazobactam Injection in China by Region, 2016-2020 Chart Sales Volume of Piperacillin and Tazobactam Injection in China, 2016-2020 Chart Sales Volume of Piperacillin and Tazobactam Injection in China by Region, 2016-2020 Chart Market Share by Sales Value of Top Piperacillin and Tazobactam Injection Manufacturers in China, 2016-2020 Chart Sales Value and Volume of TAZOCINin China, 2016-2020 Chart Sales Value and Volume of Lianbangtazuoxian in China, 2016-2020 Chart Sales Value and Volume of Shangdong Anxin Pharmaceutical Co., Ltd.’s Piperacillin and Tazobactam Injection in China, 2016-2020 Chart Sales Value and Volume of Paitaqiang in China, 2016-2020 Chart Sales Value and Volume of Beifubao in China, 2016-2020 Chart Referential Prices of TAZOCIN in China by Region, 2020-2021 Chart Referential Prices of Lianbangtazuoxian in China by Region, 2020-2021 Chart Referential Prices of Shangdong Anxin Pharmaceutical Co., Ltd.’s Piperacillin and Tazobactam Injection in China by Region, 2020-2021 Chart Referential Prices of Paitaqiang in China by Region, 2020-2021 Chart Referential Prices of Beifubao in China by Region, 2020-2021 Chart Forecast on Sales Value of Piperacillin and Tazobactam Injection in China, 2021-2025 Chart Forecast on Sales Volume of Piperacillin and Tazobactam Injection in China, 2021-2025

Related products